All In Biotech

Drug Trial Radar · NCT02286700

Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis

A Randomized, Double-Blind, Active Control, 5 Week Study to Evaluate the Safety and Skin Effects of A New, Twice-daily, Topically Applied Amino Acid Moisturizing Cream vs. Desonide Cream in Adult Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Nov 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

42

Planned (sponsor's estimate)

Start

Nov 2014

Primary completion

Feb 2015

Study completion Mar 2015

Sponsor

Lead sponsor
NeoStrata Company, Inc.Industry
Sponsor type
Industry
Collaborators
Massachusetts General Hospital
First posted
Nov 10, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.

Conditions

  • Dermatitis, Atopic
  • Eczema

Interventions

  • Desonide CreamDrug

    Study cream randomized and distributed to subjects, applied twice daily for 3 weeks and evaluated ability to reduce atopic dermatitis symptoms.

  • Amino Acid Moisturizing CreamOther

    Study cream randomized and distributed to subjects, applied twice daily for 3 weeks and evaluated ability to reduce atopic dermatitis symptoms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in skin effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.Time frame: 5 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mass General Hospital: Clinical Unit for Research Trials in Skin

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.